Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 114 | 2024 | 12985 | 6.310 |
Why?
|
Carcinoma, Pancreatic Ductal | 66 | 2024 | 1607 | 5.630 |
Why?
|
Pancreatic Neoplasms | 93 | 2024 | 5213 | 5.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 54 | 2024 | 5154 | 4.470 |
Why?
|
Adenocarcinoma | 62 | 2024 | 6318 | 4.100 |
Why?
|
Adenocarcinoma, Mucinous | 37 | 2022 | 499 | 3.900 |
Why?
|
Pancreatic Cyst | 17 | 2021 | 368 | 2.530 |
Why?
|
Barrett Esophagus | 14 | 2014 | 492 | 2.140 |
Why?
|
Immunohistochemistry | 55 | 2022 | 11347 | 1.900 |
Why?
|
Pancreas | 27 | 2021 | 1678 | 1.690 |
Why?
|
Pancreatic Ducts | 13 | 2022 | 328 | 1.500 |
Why?
|
Small Cell Lung Carcinoma | 8 | 2023 | 384 | 1.470 |
Why?
|
Carcinoma, Papillary | 18 | 2021 | 779 | 1.450 |
Why?
|
Cytodiagnosis | 9 | 2021 | 433 | 1.450 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 8 | 2023 | 199 | 1.450 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 12 | 2024 | 1029 | 1.440 |
Why?
|
Neoplasm Staging | 40 | 2022 | 10961 | 1.390 |
Why?
|
Esophageal Neoplasms | 13 | 2018 | 1575 | 1.360 |
Why?
|
Receptor Protein-Tyrosine Kinases | 16 | 2017 | 1659 | 1.340 |
Why?
|
Pancreatectomy | 19 | 2021 | 799 | 1.310 |
Why?
|
Precancerous Conditions | 12 | 2017 | 966 | 1.300 |
Why?
|
Lung | 24 | 2024 | 9782 | 1.170 |
Why?
|
Mutation | 57 | 2022 | 29658 | 1.060 |
Why?
|
Antibodies | 5 | 2021 | 2450 | 1.020 |
Why?
|
Neoplasm Invasiveness | 27 | 2022 | 3603 | 1.000 |
Why?
|
Esophagus | 12 | 2014 | 1017 | 1.000 |
Why?
|
Neoplasm Recurrence, Local | 23 | 2022 | 9122 | 0.990 |
Why?
|
Pathology | 3 | 2024 | 272 | 0.970 |
Why?
|
Humans | 376 | 2024 | 739398 | 0.960 |
Why?
|
Microsatellite Instability | 6 | 2016 | 673 | 0.900 |
Why?
|
Esophagoscopy | 7 | 2014 | 390 | 0.900 |
Why?
|
Carcinoma in Situ | 7 | 2019 | 799 | 0.880 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 19 | 2023 | 1674 | 0.860 |
Why?
|
Proto-Oncogene Proteins B-raf | 10 | 2021 | 2015 | 0.860 |
Why?
|
Gastric Mucosa | 12 | 2019 | 596 | 0.820 |
Why?
|
Aged | 162 | 2024 | 162698 | 0.820 |
Why?
|
Drug Resistance, Neoplasm | 22 | 2022 | 5148 | 0.800 |
Why?
|
Thoracic Neoplasms | 1 | 2024 | 267 | 0.800 |
Why?
|
Biopsy | 28 | 2022 | 6722 | 0.790 |
Why?
|
Idiopathic Pulmonary Fibrosis | 7 | 2024 | 446 | 0.790 |
Why?
|
Alveolitis, Extrinsic Allergic | 4 | 2017 | 61 | 0.790 |
Why?
|
Protein Kinase Inhibitors | 28 | 2022 | 5502 | 0.790 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 109 | 0.780 |
Why?
|
Prognosis | 46 | 2022 | 28901 | 0.750 |
Why?
|
Lung Diseases, Interstitial | 5 | 2024 | 804 | 0.740 |
Why?
|
Diagnosis, Differential | 36 | 2022 | 12948 | 0.730 |
Why?
|
Middle Aged | 166 | 2023 | 212863 | 0.720 |
Why?
|
Pathology, Molecular | 2 | 2020 | 325 | 0.720 |
Why?
|
Tumor Microenvironment | 16 | 2023 | 3508 | 0.710 |
Why?
|
Aged, 80 and over | 91 | 2021 | 57650 | 0.710 |
Why?
|
Male | 203 | 2024 | 349022 | 0.690 |
Why?
|
Stomach Neoplasms | 10 | 2019 | 1318 | 0.670 |
Why?
|
Colorectal Neoplasms | 14 | 2019 | 6726 | 0.630 |
Why?
|
Female | 196 | 2023 | 378853 | 0.620 |
Why?
|
Antibodies, Monoclonal | 10 | 2021 | 9259 | 0.580 |
Why?
|
Cyst Fluid | 5 | 2021 | 76 | 0.570 |
Why?
|
ras Proteins | 8 | 2020 | 1062 | 0.560 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.560 |
Why?
|
Pancreatitis | 9 | 2015 | 1082 | 0.560 |
Why?
|
Epithelial Cells | 9 | 2021 | 3671 | 0.560 |
Why?
|
Pathology, Clinical | 9 | 2017 | 363 | 0.560 |
Why?
|
Photochemotherapy | 7 | 2020 | 805 | 0.550 |
Why?
|
Tomography, Optical Coherence | 13 | 2021 | 2623 | 0.550 |
Why?
|
Translocation, Genetic | 3 | 2016 | 1416 | 0.540 |
Why?
|
Intestinal Mucosa | 14 | 2020 | 3036 | 0.520 |
Why?
|
Cystadenoma, Serous | 3 | 2021 | 102 | 0.520 |
Why?
|
Adenocarcinoma, Papillary | 5 | 2014 | 84 | 0.510 |
Why?
|
Immunodominant Epitopes | 1 | 2016 | 267 | 0.510 |
Why?
|
Celiac Disease | 4 | 2020 | 783 | 0.500 |
Why?
|
Endosonography | 11 | 2023 | 610 | 0.490 |
Why?
|
Pyrazoles | 13 | 2022 | 1963 | 0.490 |
Why?
|
Adult | 111 | 2021 | 213394 | 0.490 |
Why?
|
Pain, Intractable | 1 | 2015 | 129 | 0.490 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2016 | 310 | 0.480 |
Why?
|
Pleural Neoplasms | 4 | 2022 | 606 | 0.480 |
Why?
|
Protein-Tyrosine Kinases | 10 | 2023 | 2455 | 0.470 |
Why?
|
Carcinoma, Squamous Cell | 13 | 2023 | 4014 | 0.460 |
Why?
|
Aspergillus flavus | 1 | 2013 | 14 | 0.460 |
Why?
|
Carcinoma | 3 | 2021 | 2361 | 0.450 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 3863 | 0.450 |
Why?
|
Reproducibility of Results | 23 | 2022 | 19811 | 0.450 |
Why?
|
Observer Variation | 9 | 2020 | 2589 | 0.450 |
Why?
|
In Situ Hybridization, Fluorescence | 16 | 2022 | 2634 | 0.440 |
Why?
|
Carcinoma, Neuroendocrine | 3 | 2023 | 324 | 0.440 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 12 | 2023 | 11410 | 0.430 |
Why?
|
Esophageal Cyst | 1 | 2012 | 13 | 0.430 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3694 | 0.430 |
Why?
|
Mucins | 5 | 2009 | 563 | 0.430 |
Why?
|
Nuclear Proteins | 5 | 2021 | 5830 | 0.420 |
Why?
|
Gene Rearrangement | 5 | 2016 | 1178 | 0.420 |
Why?
|
Histocytological Preparation Techniques | 1 | 2012 | 30 | 0.420 |
Why?
|
Pathology, Surgical | 4 | 2016 | 151 | 0.410 |
Why?
|
Aspergillus fumigatus | 1 | 2013 | 150 | 0.410 |
Why?
|
Tomography, X-Ray Computed | 30 | 2024 | 20055 | 0.410 |
Why?
|
Tissue Array Analysis | 5 | 2019 | 552 | 0.400 |
Why?
|
Toxoplasmosis | 1 | 2012 | 92 | 0.400 |
Why?
|
Colonic Neoplasms | 8 | 2019 | 2530 | 0.400 |
Why?
|
Proto-Oncogene Proteins | 11 | 2023 | 4555 | 0.400 |
Why?
|
Brain Abscess | 1 | 2012 | 118 | 0.390 |
Why?
|
Autopsy | 3 | 2020 | 1004 | 0.390 |
Why?
|
Sensitivity and Specificity | 23 | 2021 | 14740 | 0.390 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2023 | 8400 | 0.390 |
Why?
|
Colon, Sigmoid | 2 | 2010 | 118 | 0.390 |
Why?
|
Retrospective Studies | 56 | 2024 | 76631 | 0.380 |
Why?
|
Cryptococcosis | 1 | 2011 | 101 | 0.380 |
Why?
|
Lung Diseases, Fungal | 1 | 2011 | 122 | 0.380 |
Why?
|
Pulmonary Fibrosis | 5 | 2017 | 525 | 0.380 |
Why?
|
Pemphigus | 1 | 2011 | 105 | 0.380 |
Why?
|
Fatal Outcome | 5 | 2020 | 1850 | 0.380 |
Why?
|
Conscious Sedation | 1 | 2015 | 528 | 0.380 |
Why?
|
Pyridines | 9 | 2020 | 2810 | 0.380 |
Why?
|
Proto-Oncogene Proteins c-met | 5 | 2020 | 578 | 0.370 |
Why?
|
Xenograft Model Antitumor Assays | 15 | 2020 | 3562 | 0.370 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 390 | 0.360 |
Why?
|
Cell Line, Tumor | 30 | 2023 | 16646 | 0.360 |
Why?
|
Immunotherapy | 9 | 2022 | 4391 | 0.360 |
Why?
|
Esophagogastric Junction | 2 | 2011 | 312 | 0.360 |
Why?
|
Adenoma | 6 | 2021 | 2167 | 0.360 |
Why?
|
Genes, erbB-1 | 3 | 2017 | 161 | 0.360 |
Why?
|
Tumor Suppressor Proteins | 3 | 2022 | 2845 | 0.360 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2012 | 161 | 0.360 |
Why?
|
Neuroendocrine Tumors | 3 | 2022 | 593 | 0.350 |
Why?
|
Antineoplastic Agents | 17 | 2020 | 13635 | 0.350 |
Why?
|
Ampulla of Vater | 4 | 2015 | 141 | 0.350 |
Why?
|
Deoxycytidine | 3 | 2020 | 825 | 0.350 |
Why?
|
Dihematoporphyrin Ether | 3 | 2011 | 31 | 0.350 |
Why?
|
Imaging, Three-Dimensional | 4 | 2018 | 4035 | 0.340 |
Why?
|
Duodenum | 1 | 2012 | 481 | 0.340 |
Why?
|
Influenza, Human | 1 | 2020 | 1476 | 0.340 |
Why?
|
DNA Mutational Analysis | 10 | 2021 | 4182 | 0.330 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1822 | 0.330 |
Why?
|
Autoimmune Diseases | 8 | 2011 | 2116 | 0.330 |
Why?
|
Chromogranins | 3 | 2018 | 162 | 0.330 |
Why?
|
Mucin-1 | 2 | 2018 | 542 | 0.320 |
Why?
|
Lung Diseases | 7 | 2021 | 1879 | 0.320 |
Why?
|
Neoadjuvant Therapy | 8 | 2024 | 2688 | 0.320 |
Why?
|
Epidermal Growth Factor | 1 | 2011 | 706 | 0.320 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 8 | 2023 | 888 | 0.320 |
Why?
|
Gastritis | 3 | 2019 | 192 | 0.320 |
Why?
|
Analgesics | 1 | 2015 | 1034 | 0.320 |
Why?
|
Fluorescent Antibody Technique | 3 | 2023 | 2503 | 0.320 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2018 | 1574 | 0.310 |
Why?
|
Lactams, Macrocyclic | 3 | 2022 | 320 | 0.310 |
Why?
|
Bronchoscopy | 4 | 2021 | 856 | 0.310 |
Why?
|
Intestinal Polyps | 1 | 2008 | 100 | 0.310 |
Why?
|
Tumor Burden | 8 | 2019 | 1904 | 0.310 |
Why?
|
Neoplastic Cells, Circulating | 4 | 2016 | 909 | 0.310 |
Why?
|
Disease-Free Survival | 9 | 2021 | 6871 | 0.310 |
Why?
|
Bile Duct Neoplasms | 4 | 2017 | 564 | 0.310 |
Why?
|
Photosensitizing Agents | 4 | 2011 | 603 | 0.300 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2009 | 264 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 9 | 2022 | 2936 | 0.300 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 3 | 2018 | 202 | 0.300 |
Why?
|
Kaplan-Meier Estimate | 12 | 2018 | 6516 | 0.300 |
Why?
|
Endoscopy | 4 | 2017 | 1762 | 0.300 |
Why?
|
Tracheal Neoplasms | 2 | 2019 | 124 | 0.300 |
Why?
|
Solitary Fibrous Tumor, Pleural | 2 | 2019 | 25 | 0.290 |
Why?
|
Radiography | 12 | 2018 | 6998 | 0.290 |
Why?
|
Acetamides | 2 | 2020 | 248 | 0.280 |
Why?
|
Esophageal Diseases | 4 | 2012 | 165 | 0.280 |
Why?
|
Stomach Diseases | 2 | 2007 | 133 | 0.280 |
Why?
|
MAP Kinase Signaling System | 4 | 2015 | 1522 | 0.280 |
Why?
|
Neoplasms | 9 | 2022 | 21507 | 0.280 |
Why?
|
Metaplasia | 5 | 2016 | 313 | 0.280 |
Why?
|
Azepines | 2 | 2020 | 335 | 0.280 |
Why?
|
Transcription Factors | 5 | 2023 | 12120 | 0.270 |
Why?
|
PTEN Phosphohydrolase | 3 | 2019 | 1142 | 0.270 |
Why?
|
Duodenitis | 2 | 2020 | 18 | 0.270 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2007 | 857 | 0.270 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2022 | 4424 | 0.270 |
Why?
|
Common Bile Duct Neoplasms | 3 | 2015 | 110 | 0.270 |
Why?
|
CA-19-9 Antigen | 3 | 2022 | 110 | 0.270 |
Why?
|
Lymphatic Metastasis | 7 | 2020 | 2897 | 0.270 |
Why?
|
Cytoskeletal Proteins | 2 | 2018 | 1369 | 0.270 |
Why?
|
Colitis | 5 | 2019 | 1146 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3143 | 0.260 |
Why?
|
Neutrophils | 2 | 2021 | 3698 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3248 | 0.260 |
Why?
|
Acrylamides | 2 | 2018 | 250 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2013 | 774 | 0.260 |
Why?
|
Abdominal Pain | 4 | 2020 | 1053 | 0.260 |
Why?
|
Biopsy, Fine-Needle | 5 | 2016 | 1089 | 0.260 |
Why?
|
Preoperative Period | 5 | 2022 | 546 | 0.250 |
Why?
|
Natural Orifice Endoscopic Surgery | 3 | 2011 | 118 | 0.250 |
Why?
|
Mice | 44 | 2023 | 81002 | 0.250 |
Why?
|
Microscopy, Confocal | 5 | 2017 | 1967 | 0.250 |
Why?
|
Animals | 73 | 2023 | 168368 | 0.250 |
Why?
|
Survival Rate | 15 | 2022 | 12761 | 0.250 |
Why?
|
Cysts | 2 | 2023 | 674 | 0.250 |
Why?
|
Papillomavirus Infections | 3 | 2022 | 1585 | 0.250 |
Why?
|
Esophagectomy | 2 | 2009 | 447 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 322 | 0.250 |
Why?
|
Antibody Specificity | 2 | 2019 | 1096 | 0.250 |
Why?
|
Hemangiosarcoma | 2 | 2023 | 228 | 0.240 |
Why?
|
Adenomatous Polyps | 2 | 2019 | 108 | 0.240 |
Why?
|
Neoplasm, Residual | 4 | 2021 | 970 | 0.240 |
Why?
|
Liver | 5 | 2021 | 7449 | 0.240 |
Why?
|
Cardia | 3 | 2014 | 57 | 0.240 |
Why?
|
Predictive Value of Tests | 9 | 2021 | 15036 | 0.240 |
Why?
|
Cystic Fibrosis | 2 | 2010 | 1177 | 0.240 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2019 | 528 | 0.230 |
Why?
|
Intestine, Small | 4 | 2020 | 1242 | 0.230 |
Why?
|
Respiratory Insufficiency | 2 | 2023 | 1197 | 0.230 |
Why?
|
Young Adult | 30 | 2022 | 56255 | 0.230 |
Why?
|
Mucin 5AC | 7 | 2020 | 93 | 0.230 |
Why?
|
Molecular Targeted Therapy | 8 | 2016 | 2727 | 0.230 |
Why?
|
Ornithine-Oxo-Acid Transaminase | 1 | 2023 | 48 | 0.230 |
Why?
|
Peptide Fragments | 1 | 2016 | 5076 | 0.230 |
Why?
|
Cytomegalovirus | 1 | 2007 | 719 | 0.220 |
Why?
|
Adenoma, Pleomorphic | 1 | 2003 | 75 | 0.220 |
Why?
|
Fibrosis | 5 | 2024 | 2024 | 0.220 |
Why?
|
Cytomegalovirus Infections | 2 | 2007 | 808 | 0.220 |
Why?
|
Hepatitis, Chronic | 1 | 2003 | 52 | 0.220 |
Why?
|
Cough | 2 | 2019 | 552 | 0.220 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2015 | 250 | 0.220 |
Why?
|
Cystadenocarcinoma, Mucinous | 2 | 2013 | 49 | 0.220 |
Why?
|
Bile Ducts | 2 | 2015 | 281 | 0.220 |
Why?
|
Aniline Compounds | 3 | 2018 | 990 | 0.220 |
Why?
|
Polyamines | 1 | 2023 | 120 | 0.220 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1603 | 0.220 |
Why?
|
Swine | 20 | 2015 | 5901 | 0.220 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3051 | 0.210 |
Why?
|
Respiratory Tract Infections | 2 | 2022 | 956 | 0.210 |
Why?
|
Survival Analysis | 12 | 2021 | 10247 | 0.210 |
Why?
|
Colon | 2 | 2011 | 1771 | 0.210 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3757 | 0.210 |
Why?
|
MAP Kinase Kinase 1 | 4 | 2017 | 338 | 0.210 |
Why?
|
Sampling Studies | 2 | 2013 | 624 | 0.210 |
Why?
|
Lymph Node Excision | 4 | 2019 | 1242 | 0.210 |
Why?
|
Pharmacy | 1 | 2023 | 89 | 0.200 |
Why?
|
Peritoneal Neoplasms | 2 | 2020 | 663 | 0.200 |
Why?
|
Carcinoma, Signet Ring Cell | 2 | 2012 | 82 | 0.200 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2021 | 61 | 0.200 |
Why?
|
Smad6 Protein | 1 | 2021 | 15 | 0.200 |
Why?
|
Colitis, Ischemic | 1 | 2021 | 31 | 0.200 |
Why?
|
Biology | 1 | 2023 | 292 | 0.200 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2021 | 74 | 0.190 |
Why?
|
Treatment Outcome | 28 | 2023 | 62693 | 0.190 |
Why?
|
Quinazolines | 5 | 2015 | 1356 | 0.190 |
Why?
|
Kupffer Cells | 1 | 2021 | 142 | 0.190 |
Why?
|
Oxonic Acid | 1 | 2020 | 41 | 0.190 |
Why?
|
Hemosiderosis | 1 | 2021 | 71 | 0.190 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 66 | 0.190 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2023 | 364 | 0.190 |
Why?
|
Polyomavirus Infections | 1 | 2023 | 196 | 0.190 |
Why?
|
Tegafur | 1 | 2020 | 49 | 0.190 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2016 | 8977 | 0.190 |
Why?
|
Nerve Tissue | 1 | 2021 | 78 | 0.190 |
Why?
|
Palliative Care | 2 | 2015 | 3461 | 0.190 |
Why?
|
Diagnostic Imaging | 6 | 2017 | 3497 | 0.190 |
Why?
|
Bronchial Neoplasms | 1 | 2021 | 112 | 0.190 |
Why?
|
Plectin | 2 | 2010 | 14 | 0.190 |
Why?
|
Cell Proliferation | 15 | 2020 | 10455 | 0.190 |
Why?
|
Practice Guidelines as Topic | 7 | 2020 | 7274 | 0.190 |
Why?
|
Disease Models, Animal | 20 | 2019 | 18003 | 0.190 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1891 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2020 | 220 | 0.190 |
Why?
|
Enterocolitis | 1 | 2021 | 102 | 0.180 |
Why?
|
Fluorouracil | 5 | 2023 | 1609 | 0.180 |
Why?
|
DNA, Neoplasm | 4 | 2016 | 1754 | 0.180 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2016 | 485 | 0.180 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2020 | 3453 | 0.180 |
Why?
|
Pancreaticoduodenectomy | 6 | 2021 | 501 | 0.180 |
Why?
|
Hepatocyte Growth Factor | 1 | 2021 | 270 | 0.180 |
Why?
|
Tumor Virus Infections | 1 | 2023 | 452 | 0.180 |
Why?
|
Carcinoma, Small Cell | 1 | 2022 | 418 | 0.180 |
Why?
|
Aortic Valve Prolapse | 1 | 2019 | 10 | 0.180 |
Why?
|
Diarrhea | 4 | 2020 | 1342 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2017 | 2507 | 0.180 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 72 | 0.180 |
Why?
|
Follow-Up Studies | 19 | 2021 | 38942 | 0.180 |
Why?
|
Liver Neoplasms | 5 | 2015 | 4216 | 0.180 |
Why?
|
Japan | 3 | 2020 | 1348 | 0.180 |
Why?
|
Colonic Polyps | 2 | 2019 | 543 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2023 | 3571 | 0.180 |
Why?
|
Phospholipase D | 1 | 2019 | 71 | 0.180 |
Why?
|
Ketone Bodies | 1 | 2019 | 82 | 0.170 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2019 | 57 | 0.170 |
Why?
|
Pleura | 1 | 2020 | 233 | 0.170 |
Why?
|
Thoracoscopy | 2 | 2011 | 178 | 0.170 |
Why?
|
Asia | 1 | 2021 | 604 | 0.170 |
Why?
|
Radiology | 2 | 2023 | 2080 | 0.170 |
Why?
|
Nomograms | 2 | 2018 | 223 | 0.170 |
Why?
|
Chest Pain | 2 | 2019 | 1112 | 0.170 |
Why?
|
Stomach | 3 | 2009 | 696 | 0.170 |
Why?
|
Lipoylation | 1 | 2019 | 64 | 0.170 |
Why?
|
Genomics | 5 | 2023 | 5652 | 0.170 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2023 | 300 | 0.170 |
Why?
|
Lymphocytosis | 2 | 2012 | 118 | 0.170 |
Why?
|
Receptor, erbB-3 | 1 | 2019 | 142 | 0.170 |
Why?
|
Collagen Type I | 2 | 2023 | 577 | 0.170 |
Why?
|
Pulmonary Medicine | 2 | 2017 | 213 | 0.170 |
Why?
|
Dyspnea | 2 | 2019 | 1295 | 0.160 |
Why?
|
Immunophenotyping | 1 | 2003 | 1858 | 0.160 |
Why?
|
Signal Transduction | 16 | 2021 | 23355 | 0.160 |
Why?
|
Calcitriol | 1 | 2020 | 298 | 0.160 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2018 | 19 | 0.160 |
Why?
|
Mice, Nude | 8 | 2020 | 3692 | 0.160 |
Why?
|
Clone Cells | 1 | 2022 | 1685 | 0.160 |
Why?
|
Multiprotein Complexes | 3 | 2013 | 1122 | 0.160 |
Why?
|
Stem Cells | 3 | 2019 | 3566 | 0.160 |
Why?
|
Histocytochemistry | 1 | 2019 | 723 | 0.160 |
Why?
|
Hemangioma | 1 | 2023 | 738 | 0.160 |
Why?
|
Jaundice | 3 | 2015 | 89 | 0.160 |
Why?
|
Pneumothorax | 1 | 2022 | 379 | 0.160 |
Why?
|
Prednisone | 2 | 2021 | 1560 | 0.160 |
Why?
|
Colitis, Collagenous | 1 | 2018 | 26 | 0.160 |
Why?
|
Crohn Disease | 3 | 2019 | 2299 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 16 | 2019 | 35326 | 0.160 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 761 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2021 | 1157 | 0.160 |
Why?
|
Dermatomyositis | 2 | 1997 | 223 | 0.160 |
Why?
|
Molecular Probes | 2 | 2017 | 318 | 0.150 |
Why?
|
Polypharmacy | 1 | 2020 | 290 | 0.150 |
Why?
|
Mucoproteins | 1 | 2017 | 50 | 0.150 |
Why?
|
Glucocorticoids | 2 | 2021 | 2100 | 0.150 |
Why?
|
Acyltransferases | 1 | 2019 | 290 | 0.150 |
Why?
|
Drug Therapy | 2 | 2018 | 497 | 0.150 |
Why?
|
bcl-X Protein | 3 | 2015 | 413 | 0.150 |
Why?
|
Receptors, Calcitriol | 1 | 2020 | 350 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2021 | 293 | 0.150 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2019 | 104 | 0.150 |
Why?
|
Cognition Disorders | 1 | 2012 | 4026 | 0.150 |
Why?
|
Immunoenzyme Techniques | 3 | 2016 | 1801 | 0.150 |
Why?
|
Prostatic Neoplasms | 1 | 2020 | 10999 | 0.150 |
Why?
|
Liver Cirrhosis | 2 | 2009 | 1838 | 0.150 |
Why?
|
Gene Amplification | 4 | 2015 | 1061 | 0.150 |
Why?
|
Tyrosine | 2 | 2020 | 1460 | 0.150 |
Why?
|
Proto-Oncogenes | 1 | 2018 | 321 | 0.150 |
Why?
|
Cyclooxygenase 2 | 2 | 2011 | 612 | 0.150 |
Why?
|
Receptor, IGF Type 1 | 1 | 2019 | 390 | 0.150 |
Why?
|
Choristoma | 2 | 2012 | 213 | 0.150 |
Why?
|
Rectal Neoplasms | 3 | 2018 | 1192 | 0.150 |
Why?
|
Neurosciences | 1 | 2022 | 347 | 0.150 |
Why?
|
Polymyositis | 1 | 1997 | 74 | 0.150 |
Why?
|
Fatty Acids | 3 | 2020 | 1804 | 0.150 |
Why?
|
Antigens, CD | 3 | 2021 | 4024 | 0.150 |
Why?
|
Feasibility Studies | 13 | 2021 | 5058 | 0.150 |
Why?
|
Microspheres | 2 | 2011 | 778 | 0.150 |
Why?
|
Azacitidine | 2 | 2017 | 344 | 0.150 |
Why?
|
Necrosis | 5 | 2013 | 1643 | 0.140 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2011 | 2397 | 0.140 |
Why?
|
Oncogene Proteins | 3 | 2017 | 750 | 0.140 |
Why?
|
Image Enhancement | 5 | 2014 | 2928 | 0.140 |
Why?
|
In Situ Hybridization | 4 | 2017 | 1934 | 0.140 |
Why?
|
Platelet Factor 4 | 1 | 2016 | 129 | 0.140 |
Why?
|
SOXB1 Transcription Factors | 1 | 2018 | 284 | 0.140 |
Why?
|
Peritoneum | 1 | 2017 | 226 | 0.140 |
Why?
|
Sulfonamides | 4 | 2015 | 1934 | 0.140 |
Why?
|
DNA Methylation | 5 | 2017 | 4269 | 0.140 |
Why?
|
Uveal Neoplasms | 1 | 2019 | 310 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 847 | 0.140 |
Why?
|
Polymerase Chain Reaction | 6 | 2014 | 6174 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1096 | 0.140 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 489 | 0.140 |
Why?
|
Pneumonia | 2 | 2022 | 2102 | 0.140 |
Why?
|
Apoptosis | 6 | 2020 | 9714 | 0.140 |
Why?
|
Adolescent | 24 | 2021 | 85405 | 0.140 |
Why?
|
Mesothelioma | 1 | 2022 | 817 | 0.140 |
Why?
|
Anti-Bacterial Agents | 4 | 2023 | 7136 | 0.130 |
Why?
|
Fever | 4 | 2013 | 1607 | 0.130 |
Why?
|
Leucovorin | 3 | 2023 | 618 | 0.130 |
Why?
|
Pulmonary Alveoli | 2 | 2022 | 677 | 0.130 |
Why?
|
Mucin-6 | 3 | 2016 | 15 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2013 | 2102 | 0.130 |
Why?
|
Enteroendocrine Cells | 1 | 2016 | 54 | 0.130 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2015 | 68 | 0.130 |
Why?
|
Aminopyridines | 4 | 2022 | 541 | 0.130 |
Why?
|
Abdominal Neoplasms | 1 | 2017 | 289 | 0.130 |
Why?
|
Pyrimidines | 6 | 2020 | 2918 | 0.130 |
Why?
|
Epithelium | 3 | 2016 | 1684 | 0.130 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12237 | 0.130 |
Why?
|
Calgranulin B | 1 | 2015 | 84 | 0.130 |
Why?
|
Drug Combinations | 1 | 2020 | 1959 | 0.130 |
Why?
|
Disease Progression | 9 | 2020 | 13237 | 0.130 |
Why?
|
Living Donors | 1 | 1999 | 617 | 0.130 |
Why?
|
Intestines | 3 | 2019 | 1919 | 0.130 |
Why?
|
Genotype | 4 | 2016 | 12951 | 0.130 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 875 | 0.130 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1611 | 0.130 |
Why?
|
Graft Rejection | 2 | 2016 | 4379 | 0.130 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2015 | 185 | 0.130 |
Why?
|
Pelvic Neoplasms | 1 | 2017 | 254 | 0.130 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12328 | 0.130 |
Why?
|
Brain | 2 | 2012 | 26345 | 0.130 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 794 | 0.130 |
Why?
|
Magnetite Nanoparticles | 2 | 2014 | 324 | 0.120 |
Why?
|
Lactams | 3 | 2022 | 156 | 0.120 |
Why?
|
Retinoblastoma Protein | 2 | 2015 | 700 | 0.120 |
Why?
|
Calcinosis | 2 | 2021 | 1493 | 0.120 |
Why?
|
Societies, Medical | 8 | 2020 | 3739 | 0.120 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 4832 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2015 | 599 | 0.120 |
Why?
|
Europe | 1 | 2021 | 3331 | 0.120 |
Why?
|
Portal Vein | 2 | 2007 | 433 | 0.120 |
Why?
|
Problem-Based Learning | 1 | 2017 | 359 | 0.120 |
Why?
|
Mediastinoscopy | 2 | 2011 | 31 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1152 | 0.120 |
Why?
|
Pulmonary Emphysema | 1 | 2019 | 670 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 648 | 0.120 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5632 | 0.120 |
Why?
|
Neoplasm Seeding | 1 | 2014 | 87 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2014 | 2933 | 0.120 |
Why?
|
Ovarian Neoplasms | 3 | 2020 | 4815 | 0.120 |
Why?
|
Cell Movement | 4 | 2020 | 5221 | 0.120 |
Why?
|
Biopsy, Needle | 4 | 2017 | 1637 | 0.120 |
Why?
|
Caloric Restriction | 2 | 2013 | 303 | 0.120 |
Why?
|
Mucous Membrane | 4 | 2010 | 667 | 0.120 |
Why?
|
Positron-Emission Tomography | 4 | 2017 | 6361 | 0.110 |
Why?
|
DNA Helicases | 2 | 2020 | 843 | 0.110 |
Why?
|
Intraoperative Care | 1 | 2017 | 766 | 0.110 |
Why?
|
Tumor Escape | 1 | 2016 | 348 | 0.110 |
Why?
|
Frameshift Mutation | 1 | 2015 | 398 | 0.110 |
Why?
|
Biliary Tract | 1 | 2014 | 134 | 0.110 |
Why?
|
Gastrointestinal Agents | 1 | 2018 | 494 | 0.110 |
Why?
|
Metabolomics | 1 | 2021 | 1460 | 0.110 |
Why?
|
Logistic Models | 4 | 2018 | 13402 | 0.110 |
Why?
|
Breast Neoplasms | 6 | 2019 | 20676 | 0.110 |
Why?
|
Gastroscopy | 4 | 2010 | 205 | 0.110 |
Why?
|
Miniaturization | 1 | 2013 | 164 | 0.110 |
Why?
|
Heterozygote | 1 | 2019 | 2798 | 0.110 |
Why?
|
Cell Nucleus | 3 | 2021 | 2965 | 0.110 |
Why?
|
Paclitaxel | 3 | 2019 | 1701 | 0.110 |
Why?
|
Ferrosoferric Oxide | 1 | 2014 | 364 | 0.110 |
Why?
|
Mice, SCID | 4 | 2020 | 2716 | 0.110 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2013 | 237 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2021 | 1391 | 0.110 |
Why?
|
Tumor Cells, Cultured | 5 | 2020 | 6310 | 0.110 |
Why?
|
Bronchogenic Cyst | 1 | 2012 | 29 | 0.110 |
Why?
|
Anemia, Pernicious | 1 | 2012 | 19 | 0.110 |
Why?
|
Stents | 3 | 2011 | 3257 | 0.110 |
Why?
|
Immunity, Humoral | 1 | 2016 | 595 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 840 | 0.100 |
Why?
|
Cell Dedifferentiation | 1 | 2013 | 134 | 0.100 |
Why?
|
Mass Screening | 2 | 2021 | 5265 | 0.100 |
Why?
|
Loss of Heterozygosity | 3 | 2014 | 678 | 0.100 |
Why?
|
Cell Lineage | 2 | 2018 | 2486 | 0.100 |
Why?
|
Genes, ras | 3 | 2018 | 693 | 0.100 |
Why?
|
Phenotype | 9 | 2018 | 16301 | 0.100 |
Why?
|
Fatty Liver | 2 | 2009 | 714 | 0.100 |
Why?
|
Laparoscopy | 2 | 2017 | 2091 | 0.100 |
Why?
|
Paneth Cells | 1 | 2012 | 100 | 0.100 |
Why?
|
Cholangiocarcinoma | 1 | 2017 | 506 | 0.100 |
Why?
|
Cohort Studies | 12 | 2020 | 40389 | 0.100 |
Why?
|
Pancreatitis, Chronic | 3 | 2016 | 284 | 0.100 |
Why?
|
Ferric Compounds | 1 | 2013 | 375 | 0.100 |
Why?
|
raf Kinases | 1 | 2012 | 122 | 0.100 |
Why?
|
Ethanol | 2 | 2009 | 1329 | 0.100 |
Why?
|
Microvilli | 2 | 2020 | 241 | 0.100 |
Why?
|
Mediastinal Diseases | 1 | 2012 | 89 | 0.100 |
Why?
|
Erythrocyte Indices | 1 | 2012 | 146 | 0.100 |
Why?
|
Automation, Laboratory | 1 | 2012 | 99 | 0.100 |
Why?
|
Risk Assessment | 8 | 2021 | 23294 | 0.100 |
Why?
|
Prospective Studies | 15 | 2021 | 53037 | 0.100 |
Why?
|
Plasma Cells | 3 | 2011 | 591 | 0.100 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 260 | 0.100 |
Why?
|
Smad4 Protein | 3 | 2016 | 162 | 0.100 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 324 | 0.100 |
Why?
|
Guanine | 1 | 2012 | 271 | 0.100 |
Why?
|
Placenta | 1 | 2020 | 1682 | 0.100 |
Why?
|
Pulmonary Infarction | 1 | 2010 | 9 | 0.100 |
Why?
|
Glutamates | 1 | 2012 | 400 | 0.100 |
Why?
|
Cystadenoma, Mucinous | 1 | 2011 | 59 | 0.100 |
Why?
|
Lymphocytes | 3 | 2009 | 2612 | 0.100 |
Why?
|
Frozen Sections | 2 | 2021 | 154 | 0.100 |
Why?
|
Algorithms | 4 | 2019 | 13872 | 0.100 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 65 | 0.100 |
Why?
|
Ornithine | 2 | 2023 | 78 | 0.100 |
Why?
|
Catheter Ablation | 2 | 2015 | 2737 | 0.090 |
Why?
|
Mice, Inbred C57BL | 9 | 2021 | 21863 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2003 | 2185 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 1431 | 0.090 |
Why?
|
Databases, Factual | 4 | 2020 | 7690 | 0.090 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2084 | 0.090 |
Why?
|
Mice, Knockout | 7 | 2019 | 14558 | 0.090 |
Why?
|
Liver Failure, Acute | 1 | 2012 | 166 | 0.090 |
Why?
|
Brain Neoplasms | 1 | 2011 | 8791 | 0.090 |
Why?
|
Lymph Nodes | 4 | 2020 | 3454 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1413 | 0.090 |
Why?
|
Proctoscopy | 1 | 2010 | 42 | 0.090 |
Why?
|
Child | 13 | 2023 | 77033 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2022 | 9387 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2022 | 2012 | 0.090 |
Why?
|
Melanoma | 4 | 2019 | 5446 | 0.090 |
Why?
|
Preoperative Care | 3 | 2018 | 2238 | 0.090 |
Why?
|
Cecal Diseases | 1 | 2010 | 51 | 0.090 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2013 | 266 | 0.090 |
Why?
|
Azathioprine | 1 | 2011 | 355 | 0.090 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 947 | 0.090 |
Why?
|
Hyperplasia | 3 | 2009 | 1181 | 0.090 |
Why?
|
Carcinoembryonic Antigen | 3 | 2016 | 347 | 0.090 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2013 | 578 | 0.090 |
Why?
|
Proteins | 2 | 2017 | 6082 | 0.090 |
Why?
|
Professional Role | 1 | 2012 | 305 | 0.090 |
Why?
|
Head and Neck Neoplasms | 1 | 2003 | 2706 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3510 | 0.090 |
Why?
|
Hyperhidrosis | 1 | 2009 | 35 | 0.090 |
Why?
|
Angiotensin II | 1 | 2013 | 880 | 0.090 |
Why?
|
Genetic Testing | 3 | 2015 | 3441 | 0.090 |
Why?
|
Telepathology | 1 | 2009 | 75 | 0.090 |
Why?
|
Liposomes | 2 | 2023 | 760 | 0.090 |
Why?
|
Sympathectomy | 1 | 2009 | 89 | 0.090 |
Why?
|
Dissection | 1 | 2011 | 293 | 0.090 |
Why?
|
Cecum | 1 | 2010 | 237 | 0.090 |
Why?
|
Watchful Waiting | 1 | 2013 | 489 | 0.080 |
Why?
|
Adipokines | 1 | 2011 | 318 | 0.080 |
Why?
|
Appendix | 1 | 2010 | 108 | 0.080 |
Why?
|
Stem Cell Niche | 1 | 2012 | 341 | 0.080 |
Why?
|
Lectins | 1 | 2011 | 517 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2008 | 566 | 0.080 |
Why?
|
Intussusception | 1 | 2010 | 117 | 0.080 |
Why?
|
Radiography, Thoracic | 2 | 2015 | 1262 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2013 | 3344 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2028 | 0.080 |
Why?
|
Liver Transplantation | 1 | 1999 | 2110 | 0.080 |
Why?
|
CpG Islands | 2 | 2009 | 1163 | 0.080 |
Why?
|
Forecasting | 1 | 2017 | 2952 | 0.080 |
Why?
|
Lipoma | 1 | 2011 | 335 | 0.080 |
Why?
|
Herpesvirus 4, Human | 2 | 2016 | 1038 | 0.080 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2009 | 75 | 0.080 |
Why?
|
Bronchiectasis | 1 | 2009 | 128 | 0.080 |
Why?
|
Neoplasm Transplantation | 3 | 2019 | 2084 | 0.080 |
Why?
|
Risk Factors | 10 | 2020 | 71974 | 0.080 |
Why?
|
Polyvinyls | 2 | 2007 | 157 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1957 | 0.080 |
Why?
|
Brachytherapy | 2 | 2008 | 1247 | 0.080 |
Why?
|
Yttrium Radioisotopes | 1 | 2008 | 94 | 0.080 |
Why?
|
Lymphoma | 1 | 2017 | 1873 | 0.080 |
Why?
|
Hematocrit | 1 | 2009 | 636 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2016 | 1154 | 0.080 |
Why?
|
ROC Curve | 4 | 2021 | 3526 | 0.080 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2007 | 25 | 0.080 |
Why?
|
Neuropeptides | 1 | 2013 | 942 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2016 | 10142 | 0.080 |
Why?
|
Thymus Gland | 1 | 2012 | 1263 | 0.080 |
Why?
|
Pilot Projects | 6 | 2021 | 8275 | 0.080 |
Why?
|
Serine | 1 | 2011 | 831 | 0.080 |
Why?
|
Camptothecin | 1 | 2011 | 570 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2013 | 2974 | 0.080 |
Why?
|
Gastrostomy | 1 | 2010 | 307 | 0.080 |
Why?
|
Pharmaceutical Solutions | 1 | 2007 | 15 | 0.080 |
Why?
|
Glycoproteins | 1 | 2015 | 2259 | 0.080 |
Why?
|
Bronchi | 3 | 2018 | 838 | 0.080 |
Why?
|
Splenic Vein | 1 | 2007 | 30 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2012 | 849 | 0.080 |
Why?
|
Endoscopy, Digestive System | 2 | 2009 | 345 | 0.080 |
Why?
|
Thiazoles | 1 | 2014 | 1488 | 0.070 |
Why?
|
Cell Differentiation | 4 | 2019 | 11460 | 0.070 |
Why?
|
Epithelioid Cells | 1 | 2007 | 71 | 0.070 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2011 | 812 | 0.070 |
Why?
|
Digestive System Neoplasms | 1 | 2007 | 87 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 245 | 0.070 |
Why?
|
Drug Resistance | 1 | 2013 | 1610 | 0.070 |
Why?
|
Collagen | 3 | 2023 | 2671 | 0.070 |
Why?
|
Immune Complex Diseases | 1 | 2006 | 54 | 0.070 |
Why?
|
Remote Consultation | 1 | 2009 | 239 | 0.070 |
Why?
|
Odds Ratio | 2 | 2017 | 9846 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1890 | 0.070 |
Why?
|
Indoles | 2 | 2013 | 1832 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4743 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8669 | 0.070 |
Why?
|
Immunoglobulin G | 5 | 2011 | 4522 | 0.070 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2013 | 643 | 0.070 |
Why?
|
Arginine | 2 | 2023 | 945 | 0.070 |
Why?
|
United States | 6 | 2021 | 69573 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2018 | 2948 | 0.070 |
Why?
|
Cell Polarity | 1 | 2010 | 644 | 0.070 |
Why?
|
Spleen | 1 | 2013 | 2359 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1548 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2013 | 827 | 0.070 |
Why?
|
Wound Healing | 2 | 2015 | 2768 | 0.070 |
Why?
|
Embolization, Therapeutic | 2 | 2007 | 1376 | 0.070 |
Why?
|
Gastroenteritis | 1 | 2008 | 245 | 0.070 |
Why?
|
Smoking | 3 | 2019 | 8960 | 0.070 |
Why?
|
Patient Care Team | 1 | 2017 | 2527 | 0.070 |
Why?
|
Immunoblotting | 3 | 2015 | 1683 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2014 | 740 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2011 | 845 | 0.070 |
Why?
|
Ultrasonography, Interventional | 3 | 2011 | 1480 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 7 | 2018 | 17384 | 0.070 |
Why?
|
Urogenital Neoplasms | 1 | 2007 | 135 | 0.070 |
Why?
|
Radiography, Abdominal | 1 | 2009 | 535 | 0.070 |
Why?
|
Virus Latency | 1 | 2008 | 356 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 425 | 0.070 |
Why?
|
Hepatic Encephalopathy | 1 | 2007 | 139 | 0.070 |
Why?
|
Blood Platelets | 1 | 2016 | 2506 | 0.070 |
Why?
|
DNA Mismatch Repair | 1 | 2009 | 423 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10362 | 0.070 |
Why?
|
RNA Interference | 4 | 2016 | 2899 | 0.070 |
Why?
|
Models, Animal | 5 | 2010 | 2164 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2017 | 5863 | 0.070 |
Why?
|
Video Recording | 2 | 2009 | 936 | 0.070 |
Why?
|
Workflow | 2 | 2022 | 831 | 0.070 |
Why?
|
Consensus | 3 | 2024 | 2913 | 0.070 |
Why?
|
Iatrogenic Disease | 1 | 2008 | 544 | 0.060 |
Why?
|
Cyclins | 1 | 2007 | 601 | 0.060 |
Why?
|
Pancreatic Diseases | 1 | 2007 | 350 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 2986 | 0.060 |
Why?
|
Mesentery | 1 | 2005 | 205 | 0.060 |
Why?
|
Rectum | 1 | 2010 | 900 | 0.060 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2009 | 382 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2267 | 0.060 |
Why?
|
Bleomycin | 2 | 2017 | 496 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3514 | 0.060 |
Why?
|
Energy Intake | 1 | 2012 | 2135 | 0.060 |
Why?
|
Microsurgery | 1 | 2010 | 793 | 0.060 |
Why?
|
Health Personnel | 1 | 2017 | 3203 | 0.060 |
Why?
|
Intermediate Filament Proteins | 1 | 2005 | 269 | 0.060 |
Why?
|
Prosthesis Failure | 2 | 2015 | 1203 | 0.060 |
Why?
|
Octamer Transcription Factors | 1 | 2023 | 23 | 0.060 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2019 | 253 | 0.060 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2409 | 0.060 |
Why?
|
Amyloidosis | 1 | 2010 | 789 | 0.060 |
Why?
|
Creatinine | 1 | 2009 | 1903 | 0.060 |
Why?
|
Cell Line | 4 | 2021 | 15987 | 0.060 |
Why?
|
Ribosomal Protein S6 | 2 | 2013 | 70 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 12049 | 0.060 |
Why?
|
Oxidation-Reduction | 2 | 2020 | 2184 | 0.060 |
Why?
|
International Agencies | 2 | 2016 | 240 | 0.060 |
Why?
|
Clinical Trials as Topic | 3 | 2022 | 7897 | 0.060 |
Why?
|
Hypesthesia | 1 | 2024 | 110 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1867 | 0.060 |
Why?
|
Keratins | 1 | 2005 | 516 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2012 | 873 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8274 | 0.060 |
Why?
|
Transforming Growth Factor beta | 2 | 2021 | 1997 | 0.060 |
Why?
|
Microscopy | 1 | 2008 | 899 | 0.060 |
Why?
|
Genes, APC | 1 | 2003 | 159 | 0.060 |
Why?
|
Prevalence | 2 | 2017 | 15153 | 0.060 |
Why?
|
Sulfones | 2 | 2016 | 436 | 0.060 |
Why?
|
Drug Synergism | 2 | 2019 | 1792 | 0.060 |
Why?
|
Contrast Media | 5 | 2019 | 5293 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2019 | 4546 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2006 | 623 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2009 | 806 | 0.050 |
Why?
|
Immunoglobulin M | 1 | 2007 | 1537 | 0.050 |
Why?
|
Cell Survival | 3 | 2019 | 5877 | 0.050 |
Why?
|
Genetic Heterogeneity | 2 | 2017 | 727 | 0.050 |
Why?
|
Ultrasonography | 2 | 2013 | 5941 | 0.050 |
Why?
|
Mediastinum | 1 | 2023 | 267 | 0.050 |
Why?
|
Nanoparticles | 1 | 2013 | 1906 | 0.050 |
Why?
|
Incidence | 2 | 2017 | 20913 | 0.050 |
Why?
|
Injections | 3 | 2011 | 837 | 0.050 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2003 | 224 | 0.050 |
Why?
|
DNA, Viral | 1 | 2008 | 2223 | 0.050 |
Why?
|
Clozapine | 1 | 2005 | 498 | 0.050 |
Why?
|
Computational Biology | 3 | 2021 | 3506 | 0.050 |
Why?
|
Child, Preschool | 4 | 2017 | 40802 | 0.050 |
Why?
|
Human papillomavirus 18 | 1 | 2022 | 127 | 0.050 |
Why?
|
Time Factors | 6 | 2020 | 40050 | 0.050 |
Why?
|
Serous Membrane | 1 | 2021 | 28 | 0.050 |
Why?
|
Piperazines | 3 | 2019 | 2480 | 0.050 |
Why?
|
Alcoholism | 1 | 2012 | 1892 | 0.050 |
Why?
|
Guanidines | 1 | 2022 | 191 | 0.050 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2022 | 116 | 0.050 |
Why?
|
Intestinal Diseases | 1 | 2006 | 531 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 284 | 0.050 |
Why?
|
Esters | 1 | 2022 | 210 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2021 | 9734 | 0.050 |
Why?
|
Gene Silencing | 1 | 2007 | 1537 | 0.050 |
Why?
|
Up-Regulation | 2 | 2021 | 4205 | 0.050 |
Why?
|
Eosinophilia | 1 | 2005 | 531 | 0.050 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 504 | 0.050 |
Why?
|
Enzyme Stability | 1 | 2021 | 210 | 0.050 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1070 | 0.050 |
Why?
|
Mitotic Index | 1 | 2020 | 171 | 0.050 |
Why?
|
Human papillomavirus 16 | 1 | 2022 | 261 | 0.050 |
Why?
|
Ki-67 Antigen | 2 | 2016 | 642 | 0.050 |
Why?
|
Aging | 1 | 2019 | 8613 | 0.050 |
Why?
|
Phosphorylation | 3 | 2019 | 8416 | 0.050 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8605 | 0.050 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 164 | 0.050 |
Why?
|
Genome, Human | 2 | 2015 | 4419 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2019 | 1214 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2009 | 1786 | 0.050 |
Why?
|
Risk | 1 | 2012 | 9684 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2007 | 1127 | 0.050 |
Why?
|
Infant | 3 | 2012 | 34923 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2014 | 10945 | 0.050 |
Why?
|
Receptors, CXCR | 1 | 2020 | 53 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 1834 | 0.050 |
Why?
|
Angiography | 1 | 2005 | 1634 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 2019 | 16 | 0.050 |
Why?
|
North America | 2 | 2018 | 1249 | 0.050 |
Why?
|
Patient Selection | 1 | 2012 | 4211 | 0.040 |
Why?
|
Coronary Restenosis | 1 | 2003 | 423 | 0.040 |
Why?
|
Cell Communication | 2 | 2020 | 1618 | 0.040 |
Why?
|
Gene Dosage | 2 | 2015 | 1251 | 0.040 |
Why?
|
Recurrence | 4 | 2015 | 8307 | 0.040 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2019 | 88 | 0.040 |
Why?
|
Gastroesophageal Reflux | 1 | 2006 | 782 | 0.040 |
Why?
|
Hepatitis, Viral, Human | 1 | 1999 | 137 | 0.040 |
Why?
|
Tissue Preservation | 1 | 1999 | 178 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 449 | 0.040 |
Why?
|
Pneumonectomy | 2 | 2020 | 1091 | 0.040 |
Why?
|
Mediastinal Neoplasms | 1 | 2002 | 421 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1899 | 0.040 |
Why?
|
Enzyme Repression | 1 | 2018 | 32 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5702 | 0.040 |
Why?
|
Cholangitis | 1 | 1999 | 108 | 0.040 |
Why?
|
Blood Group Incompatibility | 1 | 1999 | 145 | 0.040 |
Why?
|
Benzamides | 2 | 2015 | 1374 | 0.040 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 90 | 0.040 |
Why?
|
Phosphoproteins | 1 | 2007 | 2440 | 0.040 |
Why?
|
src Homology Domains | 1 | 2019 | 365 | 0.040 |
Why?
|
Hedgehog Proteins | 2 | 2016 | 774 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2018 | 51 | 0.040 |
Why?
|
Hematoxylin | 1 | 2018 | 63 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2022 | 591 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 364 | 0.040 |
Why?
|
Histocompatibility | 1 | 1999 | 331 | 0.040 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2018 | 71 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4143 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 97 | 0.040 |
Why?
|
Rhabdoid Tumor | 1 | 2020 | 211 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2007 | 1232 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 315 | 0.040 |
Why?
|
Macrophages | 1 | 2013 | 5631 | 0.040 |
Why?
|
Virus Internalization | 1 | 2022 | 499 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2022 | 792 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2023 | 3435 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2010 | 2091 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 2020 | 462 | 0.040 |
Why?
|
Coronary Disease | 1 | 2012 | 6068 | 0.040 |
Why?
|
Point Mutation | 2 | 2015 | 1626 | 0.040 |
Why?
|
Sigmoidoscopy | 1 | 2018 | 156 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2018 | 387 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 1116 | 0.040 |
Why?
|
Down-Regulation | 2 | 2016 | 2999 | 0.040 |
Why?
|
Medical Oncology | 2 | 2022 | 2217 | 0.040 |
Why?
|
Endoderm | 1 | 2018 | 150 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2009 | 3280 | 0.040 |
Why?
|
Popliteal Cyst | 1 | 1996 | 9 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 781 | 0.040 |
Why?
|
Transfection | 2 | 2016 | 5884 | 0.040 |
Why?
|
Inflammation | 4 | 2021 | 10534 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 357 | 0.040 |
Why?
|
Mucin-2 | 2 | 2008 | 49 | 0.040 |
Why?
|
Amylases | 1 | 2016 | 172 | 0.040 |
Why?
|
Ischemia | 1 | 2005 | 1908 | 0.040 |
Why?
|
Sus scrofa | 2 | 2010 | 437 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2277 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2017 | 99 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2017 | 409 | 0.040 |
Why?
|
Gallium Radioisotopes | 1 | 2017 | 168 | 0.040 |
Why?
|
Genes, erbB-2 | 1 | 2017 | 162 | 0.040 |
Why?
|
Dermatologic Agents | 1 | 2020 | 274 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2007 | 3151 | 0.030 |
Why?
|
Pharyngeal Muscles | 1 | 1996 | 77 | 0.030 |
Why?
|
Cricoid Cartilage | 1 | 1996 | 72 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2022 | 1117 | 0.030 |
Why?
|
Purines | 1 | 2019 | 593 | 0.030 |
Why?
|
Cisplatin | 2 | 2019 | 1617 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 1 | 1999 | 525 | 0.030 |
Why?
|
Neprilysin | 2 | 2009 | 439 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2016 | 156 | 0.030 |
Why?
|
Thrombophlebitis | 1 | 1996 | 309 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1203 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2016 | 178 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 760 | 0.030 |
Why?
|
Genes, cdc | 1 | 2016 | 117 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1602 | 0.030 |
Why?
|
Cell Count | 2 | 2012 | 1833 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 982 | 0.030 |
Why?
|
Bronchography | 1 | 1995 | 74 | 0.030 |
Why?
|
Injections, Intralesional | 2 | 2006 | 276 | 0.030 |
Why?
|
Cystadenoma | 1 | 2015 | 84 | 0.030 |
Why?
|
Sirolimus | 2 | 2013 | 1559 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1350 | 0.030 |
Why?
|
Forms and Records Control | 1 | 2016 | 160 | 0.030 |
Why?
|
Chronic Disease | 3 | 2019 | 9133 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2005 | 2639 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2020 | 726 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1321 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2015 | 83 | 0.030 |
Why?
|
Genes, p16 | 1 | 2015 | 157 | 0.030 |
Why?
|
Regeneration | 2 | 2015 | 1467 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12643 | 0.030 |
Why?
|
Imidazoles | 1 | 2021 | 1207 | 0.030 |
Why?
|
Genes, myc | 1 | 2016 | 399 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 2015 | 2370 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2018 | 1883 | 0.030 |
Why?
|
Cysteine | 1 | 2019 | 870 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2019 | 737 | 0.030 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2014 | 146 | 0.030 |
Why?
|
Computer-Assisted Instruction | 1 | 2017 | 363 | 0.030 |
Why?
|
Filtration | 1 | 2015 | 235 | 0.030 |
Why?
|
Database Management Systems | 1 | 2016 | 272 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 105 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 409 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 970 | 0.030 |
Why?
|
Hepatitis B | 1 | 1999 | 688 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2019 | 788 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2007 | 5012 | 0.030 |
Why?
|
Choroid Neoplasms | 1 | 1995 | 175 | 0.030 |
Why?
|
Collagen Diseases | 1 | 1994 | 34 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 1182 | 0.030 |
Why?
|
Blotting, Western | 2 | 2013 | 5181 | 0.030 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 290 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1108 | 0.030 |
Why?
|
Pharynx | 1 | 1996 | 411 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 473 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2004 | 2037 | 0.030 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2014 | 209 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7275 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 378 | 0.030 |
Why?
|
Age Factors | 3 | 2017 | 18349 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2017 | 799 | 0.030 |
Why?
|
Click Chemistry | 1 | 2013 | 97 | 0.030 |
Why?
|
Molecular Probe Techniques | 1 | 2013 | 121 | 0.030 |
Why?
|
Embryonic Development | 1 | 2018 | 701 | 0.030 |
Why?
|
Doxorubicin | 1 | 2019 | 2218 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 744 | 0.030 |
Why?
|
Acute Disease | 3 | 2015 | 7128 | 0.030 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
Cyclic ADP-Ribose | 1 | 2012 | 17 | 0.030 |
Why?
|
Pyrophosphatases | 1 | 2013 | 137 | 0.030 |
Why?
|
Ilium | 1 | 2013 | 155 | 0.030 |
Why?
|
Teaching | 1 | 2020 | 1166 | 0.030 |
Why?
|
Thymidylate Synthase | 1 | 2012 | 74 | 0.030 |
Why?
|
Neuregulin-1 | 1 | 2013 | 141 | 0.030 |
Why?
|
Mitochondria | 2 | 2017 | 3522 | 0.030 |
Why?
|
Megakaryocytes | 1 | 2016 | 542 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 464 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 560 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2015 | 524 | 0.030 |
Why?
|
Hepatectomy | 2 | 2006 | 550 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 643 | 0.030 |
Why?
|
Thymectomy | 1 | 2012 | 192 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1280 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2907 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2005 | 3055 | 0.030 |
Why?
|
Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.030 |
Why?
|
HT29 Cells | 1 | 2012 | 200 | 0.030 |
Why?
|
Sternotomy | 1 | 2012 | 121 | 0.030 |
Why?
|
Reoperation | 1 | 2021 | 4192 | 0.030 |
Why?
|
Callitrichinae | 1 | 2011 | 23 | 0.020 |
Why?
|
Radiotherapy Dosage | 2 | 2010 | 2872 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2183 | 0.020 |
Why?
|
Cadherins | 1 | 2016 | 901 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2015 | 1585 | 0.020 |
Why?
|
Postoperative Complications | 5 | 2015 | 15194 | 0.020 |
Why?
|
Paresthesia | 1 | 2012 | 159 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2016 | 804 | 0.020 |
Why?
|
Ketoglutaric Acids | 1 | 2011 | 78 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2020 | 2256 | 0.020 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2012 | 116 | 0.020 |
Why?
|
Sarcoidosis | 1 | 1996 | 507 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 399 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1339 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 433 | 0.020 |
Why?
|
Gastroscopes | 1 | 2010 | 19 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1654 | 0.020 |
Why?
|
Hamartoma | 1 | 2013 | 236 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3193 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2012 | 276 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4174 | 0.020 |
Why?
|
Sphingosine | 1 | 2013 | 306 | 0.020 |
Why?
|
Incidental Findings | 1 | 2015 | 690 | 0.020 |
Why?
|
Veratrum Alkaloids | 1 | 2010 | 25 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 625 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 1996 | 607 | 0.020 |
Why?
|
Kidney | 3 | 2017 | 7144 | 0.020 |
Why?
|
Genes, p53 | 1 | 2013 | 752 | 0.020 |
Why?
|
Lysophospholipids | 1 | 2013 | 330 | 0.020 |
Why?
|
Citric Acid Cycle | 1 | 2011 | 230 | 0.020 |
Why?
|
Bronchiolitis | 1 | 1996 | 449 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1018 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2016 | 4791 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1793 | 0.020 |
Why?
|
Western World | 1 | 2009 | 27 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2430 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 976 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2016 | 2238 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2011 | 335 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2010 | 334 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 2971 | 0.020 |
Why?
|
Syncope | 1 | 2012 | 431 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3194 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1734 | 0.020 |
Why?
|
Hepatitis C | 1 | 1999 | 1580 | 0.020 |
Why?
|
Hemoptysis | 1 | 2010 | 155 | 0.020 |
Why?
|
Esophagitis | 1 | 2010 | 151 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1849 | 0.020 |
Why?
|
Cell Separation | 1 | 2015 | 1739 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 2381 | 0.020 |
Why?
|
Boston | 2 | 2017 | 9314 | 0.020 |
Why?
|
Serologic Tests | 1 | 2011 | 373 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 1994 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2016 | 2515 | 0.020 |
Why?
|
Antiphospholipid Syndrome | 1 | 2010 | 173 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2009 | 295 | 0.020 |
Why?
|
Family | 1 | 1999 | 3141 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1783 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2011 | 982 | 0.020 |
Why?
|
Foreign-Body Migration | 1 | 2010 | 222 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3701 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2011 | 685 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2026 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1890 | 0.020 |
Why?
|
Cytarabine | 1 | 2010 | 685 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2008 | 185 | 0.020 |
Why?
|
Drug Interactions | 1 | 2012 | 1456 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2014 | 2373 | 0.020 |
Why?
|
Prescriptions | 1 | 2010 | 383 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 3146 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3606 | 0.020 |
Why?
|
Thoracotomy | 1 | 2009 | 365 | 0.020 |
Why?
|
Venous Pressure | 1 | 2007 | 56 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2015 | 21694 | 0.020 |
Why?
|
Anal Canal | 1 | 2010 | 373 | 0.020 |
Why?
|
Computer Systems | 1 | 2008 | 484 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2009 | 903 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2687 | 0.020 |
Why?
|
Submandibular Gland | 1 | 2006 | 86 | 0.020 |
Why?
|
Abscess | 1 | 2010 | 605 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6397 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 603 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3615 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2013 | 1777 | 0.020 |
Why?
|
Pressure | 1 | 2010 | 1201 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 12655 | 0.020 |
Why?
|
Schizophrenia | 1 | 2005 | 6866 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1213 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2010 | 983 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3922 | 0.020 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2006 | 66 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7298 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2417 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1539 | 0.020 |
Why?
|
Irritable Bowel Syndrome | 1 | 2011 | 441 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2011 | 659 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2007 | 462 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2011 | 1168 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 789 | 0.020 |
Why?
|
Keratin-20 | 1 | 2005 | 31 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8039 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2009 | 1581 | 0.020 |
Why?
|
Rats | 1 | 2022 | 24270 | 0.020 |
Why?
|
Keratin-7 | 1 | 2005 | 57 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1129 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 2015 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1096 | 0.020 |
Why?
|
Lasers | 1 | 2009 | 945 | 0.020 |
Why?
|
Databases, Bibliographic | 1 | 2005 | 129 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1082 | 0.020 |
Why?
|
Pyloric Antrum | 1 | 2005 | 68 | 0.020 |
Why?
|
Genetic Variation | 2 | 2012 | 6539 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 4012 | 0.020 |
Why?
|
RNA | 1 | 2015 | 2723 | 0.020 |
Why?
|
International Cooperation | 1 | 2011 | 1420 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 1175 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 2006 | 517 | 0.020 |
Why?
|
Genome, Viral | 1 | 2008 | 668 | 0.020 |
Why?
|
Blood Sedimentation | 1 | 2005 | 232 | 0.020 |
Why?
|
Cell Division | 1 | 2012 | 4575 | 0.020 |
Why?
|
Curriculum | 1 | 2017 | 3575 | 0.020 |
Why?
|
Longevity | 1 | 2012 | 1066 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5272 | 0.020 |
Why?
|
Hypotension | 1 | 2010 | 881 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2005 | 299 | 0.020 |
Why?
|
Genetics, Population | 1 | 2009 | 931 | 0.020 |
Why?
|
Postoperative Care | 1 | 2011 | 1477 | 0.020 |
Why?
|
Adenoma, Villous | 1 | 2003 | 15 | 0.010 |
Why?
|
Glutens | 1 | 2006 | 230 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2016 | 2950 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 1996 | 2365 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9375 | 0.010 |
Why?
|
Intestinal Neoplasms | 1 | 2006 | 319 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2008 | 1725 | 0.010 |
Why?
|
Bacteremia | 1 | 2010 | 957 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3614 | 0.010 |
Why?
|
Software | 1 | 2018 | 4423 | 0.010 |
Why?
|
Goblet Cells | 1 | 2006 | 288 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6942 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2005 | 888 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2012 | 1441 | 0.010 |
Why?
|
Pelvis | 1 | 2007 | 718 | 0.010 |
Why?
|
Catheterization | 1 | 2008 | 1466 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3908 | 0.010 |
Why?
|
Peptides | 1 | 2015 | 4395 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 1580 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9622 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 3909 | 0.010 |
Why?
|
Atherectomy, Coronary | 1 | 2003 | 148 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2012 | 2265 | 0.010 |
Why?
|
Anemia | 1 | 2012 | 1498 | 0.010 |
Why?
|
NF-kappa B | 1 | 2011 | 2502 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3583 | 0.010 |
Why?
|
Clinical Competence | 1 | 2017 | 4671 | 0.010 |
Why?
|
Morbidity | 1 | 2007 | 1763 | 0.010 |
Why?
|
Abdomen | 1 | 2007 | 1104 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 1625 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2011 | 2261 | 0.010 |
Why?
|
Weight Loss | 1 | 2012 | 2589 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2007 | 1184 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3364 | 0.010 |
Why?
|
Genetic Counseling | 1 | 2003 | 601 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4400 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7788 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 5959 | 0.010 |
Why?
|
Food Hypersensitivity | 1 | 2006 | 613 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2012 | 1947 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3433 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 24714 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29002 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5522 | 0.010 |
Why?
|
Thoracic Surgical Procedures | 1 | 2002 | 342 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2012 | 3517 | 0.010 |
Why?
|
Tin Compounds | 1 | 1996 | 8 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12804 | 0.010 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 1996 | 66 | 0.010 |
Why?
|
Length of Stay | 1 | 2010 | 6295 | 0.010 |
Why?
|
Vindesine | 1 | 1995 | 12 | 0.010 |
Why?
|
Pedigree | 1 | 2003 | 4640 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15500 | 0.010 |
Why?
|
Phlebography | 1 | 1996 | 333 | 0.010 |
Why?
|
Poliomyelitis | 1 | 1996 | 104 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 18125 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10398 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 19220 | 0.010 |
Why?
|
Mitomycin | 1 | 1995 | 259 | 0.010 |
Why?
|
Serum Albumin | 1 | 1996 | 669 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3504 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1996 | 2028 | 0.010 |
Why?
|
Carboplatin | 1 | 1995 | 800 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15511 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2003 | 4560 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 11699 | 0.000 |
Why?
|
Kidney Neoplasms | 1 | 1995 | 4189 | 0.000 |
Why?
|